Lv1
30 积分 2026-06-07 加入
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
17小时前
已完结
Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
1天前
已完结
Chinese guidelines for diagnosis and treatment of neuromyelitis optica spectrum disorders (2025 edition)
1天前
已完结
Real-world safety of satralizumab in neuromyelitis optica spectrum disorder: a FAERS-based risk stratification study
1个月前
已完结